General Information
Sunovion SEP361-303
An Open-label Extension Study to Assess the Safety and Tolerability of SEP-363856 in Subjects with Schizophrenia
| Protocol | SEP361-303 |
|---|---|
| Identifier | |
| UID | 8b068e62-7c1a-4447-a50e-3522ee7e5693 |
| Status | Done - Archived |
| Phase | |
| Category | Schizophrenia / Adult |
| Launch Year | 2020 |
| NCT Number | - |
| Created | 2019-08-19 11:07 |
| Last Updated | 2024-01-22 22:05 |
Description
No description provided.
Comment
No comment.
Target Dates
| Name | Date | Required |
|---|---|---|
| Enrollment Closed | 2020-06-15 | No |
| Enrollment Open | 2020-03-10 | No |
| First Patient First Visit | No | |
| Site Initiation Mtg. | 2020-02-26 | No |
| PI Meeting Start | No | |
| PI Meeting End | No | |
| PI Meeting Arrival | No | |
| PI Meeting Departure | No | |
| Closeout Date | 2024-02-21 | No |
| Final PatientVisit | No | |
| PreStudy Selection Visit | No | |
| Target Date 12 | No | |
| Target Date 13 | No | |
| Target Date 14 | No |
Leadership
| Role | Staff | Login | Required |
|---|---|---|---|
| Principal | Volk, Stephen | SVolk | No |
| Recruiter | - | No | |
| Coordinator | Sandoval, Larry | LSandoval | No |
| Regulatory | Ramirez, Claudia | CRamirez | No |
Custom Fields
No custom fields.
Sponsor & Organization
| Sponsor | Sunovion Pharmaceuticals Inc. |
|---|---|
| Division | Sunovion Pharmaceuticals Inc. |
| Team | Sunovion Pharmaceuticals Inc. |
| Managing Site | Catalina Research Institute, LLC |
| Organization |
Contacts
| IRB Ref | |
|---|---|
| CRO | IQVIA RDS Inc. |
| CRO Ref | |
| Correspondence | 0 |
Opportunity
| Probability | 0 |
|---|---|
| Comment | |
| Status Color | Gainsboro |
| Currency | - |
